Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
US7834178B2 · kind B2 · utility
9Cited by
13References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 28, 2007 |
| Grant date | Nov 16, 2010 |
| Priority date | — |
| Expiry date | Dec 29, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D253/07
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure:or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof, wherein R1, R2 and R3 are defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.